Leadless Pacemakers: Durability, Retrieval, and Clinical Follow-Up
Leadless pacemakers have moved from a niche alternative to an established option for selected patients who need ventricular pacing. By placing the generator and electrodes inside the heart, these systems avoid a subcutaneous pocket and eliminate the transvenous lead, two components responsible for many conventional pacemaker complications. Their value is especially apparent in patients with limited venous access, previous device infection, or a high risk of pocket problems.
Long-term assessment requires more than a review of implant success. Clinicians must consider battery depletion, pacing performance, chronic device retrieval, device-to-device interactions, infection risk, and the consequences of leaving an old capsule in the right ventricle. These questions become increasingly important as the first generation of recipients reach the point of generator replacement.
Evidence continues to develop through registries, prospective studies, imaging research, and real-world follow-up. Readers tracking this field can explore current and past electrophysiology research through the journal’s arrhythmia article collection, where studies on pacing, implantation techniques, and device management sit alongside broader work in cardiac rhythm care.
How The Technology Has Evolved
The first commercially available leadless pacemakers were designed primarily for single-chamber ventricular pacing. Their small, self-contained design addressed the limitations of a pulse generator implanted under the skin and a lead threaded through the venous system. Early experience established reliable short-term capture thresholds and acceptable sensing, while also identifying procedure-specific risks such as cardiac perforation, vascular injury, and device dislodgement.
Newer platforms have expanded the clinical range. Some systems provide improved battery capacity, remote monitoring, and options for atrioventricular synchrony through sensing of atrial mechanical activity. Dual-chamber leadless concepts are also being evaluated, although their use, programming strategies, and long-term evidence remain less mature than those of conventional dual-chamber pacemakers.
The evolution of delivery systems has influenced safety as much as generator design. Smaller introducer profiles, better deployment control, and greater operator experience can reduce vascular complications and improve positioning. Even so, patient selection remains central because a leadless device does not automatically solve every pacing requirement.
Long-Term Electrical Performance
The most useful measures of durability are pacing threshold, R-wave amplitude, impedance, battery consumption, and the percentage of time pacing is required. In many recipients, electrical parameters stabilize after implantation and remain clinically acceptable over years of follow-up. A low and stable capture threshold is particularly important because it preserves battery life and reduces the chance of premature replacement.
Battery longevity varies according to pacing output, programmed rate, pacing burden, device model, and patient-specific rhythm changes. A person with intermittent bradycardia may use substantially less energy than someone who is pacemaker-dependent. Follow-up should therefore interpret projected longevity alongside actual pacing behavior rather than treating a manufacturer estimate as a fixed endpoint.
Longitudinal surveillance also identifies changes that may be clinically silent. A rising threshold can reflect altered contact with the myocardium, fibrosis, microdislodgement, or programming issues. Declining sensing may affect inhibition and pacing reliability. Remote monitoring can detect trends between clinic visits, but it does not replace assessment of symptoms, underlying rhythm, and the patient’s future need for pacing.
Retrieval After Chronic Implantation
Extraction is often straightforward soon after implantation, before substantial tissue ingrowth develops. The procedure becomes more complex as the device becomes encapsulated by fibrous tissue. Retrieval may require a snare, a dedicated sheath, femoral venous access, or advanced tools capable of dissecting tissue around the docking feature. Experience is concentrated in specialized centers, and procedural planning should account for device age, implant position, thrombotic risk, and the reason for removal.
Published experience suggests that chronic retrieval can be successful, but success rates and complication profiles depend heavily on patient selection and operator expertise. Potential hazards include vascular injury, cardiac perforation, tamponade, embolization, and damage to nearby implanted devices. A retrieval strategy should therefore be developed before the procedure, with surgical or interventional backup available when risk is substantial.
The decision to retrieve is not identical to the decision to replace. If a leadless pacemaker reaches battery depletion and another unit can be safely implanted, leaving the old device in place may avoid extraction risk. A second device must, however, fit within the available ventricular space without compromising function or creating unacceptable device interaction. Retrieval becomes more compelling when infection, malfunction, dislodgement, thrombus, or limited room for additional implants is present.
| Clinical issue | What long-term follow-up should assess | Practical implication |
|---|---|---|
| Capture threshold | Stability, trend, and output required for reliable pacing | Rising values may shorten battery life or signal device-tissue change |
| Sensing | R-wave amplitude and rhythm discrimination | Poor sensing can affect pacing safety and diagnostic accuracy |
| Battery status | Estimated longevity, pacing burden, and programmed output | Replacement planning should begin before elective replacement indicators |
| Device position | Symptoms, imaging when indicated, and evidence of migration | Late movement is uncommon but may require intervention |
| Infection | Fever, bacteremia, endocarditis, and local or systemic signs | Removal decisions should involve an experienced extraction team |
| Future pacing need | Dependence, rhythm evolution, and AV synchrony requirements | A replacement strategy should be individualized rather than automatic |
Infection And Other Late Complications
Eliminating the pocket and transvenous lead substantially changes the infection profile. Leadless systems generally avoid pocket erosion, hematoma, and lead fracture, and reported infection rates are low. Nevertheless, infection can still occur, particularly in patients with bacteremia, endocarditis, repeated invasive procedures, immunosuppression, or other major comorbidities. A leadless generator is still foreign material within the cardiovascular system and cannot be considered infection-proof.
Late complications may include loss of capture, elevated thresholds, device migration, thrombus, and complications related to vascular access. Some problems are detected through routine interrogation, while others appear as syncope, worsening fatigue, dyspnea, or recurrent pauses. A symptom-driven evaluation should include electrocardiography, device interrogation, medication review, and assessment of the underlying conduction disorder.
The absence of a chest incision can also create false reassurance. Patients should receive clear instructions about fever, unexplained bacteremia, recurrent presyncope, and new exercise intolerance. Structured follow-up is particularly important for older adults and for patients whose dependence on pacing may increase as conduction disease progresses.
Choosing Patients And Planning Replacement
Leadless pacing is most compelling when the benefits of avoiding a pocket and lead outweigh the limitations of intracardiac implantation. Suitable candidates may include patients with permanent atrial fibrillation and slow ventricular response, difficult venous anatomy, prior device infection, limited vascular access, or high risk of lead-related complications. It may also be useful when preserving upper-body veins is important for future dialysis access.
The technology is less suitable when dependable atrial pacing, complex resynchronization, or robust physiologic pacing is required. Patients with expected high pacing burdens should be assessed carefully for ventricular function and the possibility of pacing-induced dysfunction. The availability of a dual-chamber or conduction-system alternative may alter the balance of benefits and risks.
Replacement planning should begin well before battery depletion. The team should review pacing dependence, current device position, venous access, anticoagulation, infection history, and the feasibility of retrieval. Options may include implanting an additional leadless unit, retrieving the old device and replacing it, or transitioning to a transvenous system. A documented plan reduces the likelihood of urgent decisions when battery reserve is limited.
Building A Reliable Follow-Up Program
Long-term care works best when implantation data are recorded in a way that supports later decisions. The initial report should include device model, implant site, electrical measurements, delivery approach, complications, and programmed parameters. These details can be critical years later when an extraction specialist evaluates the device or when imaging raises uncertainty about its position.
Follow-up intervals should reflect patient dependence, battery status, electrical trends, and the reliability of remote monitoring. In-person reviews remain valuable for checking symptoms, confirming programming, assessing comorbid disease, and discussing future procedures. Imaging is not required routinely for every patient, but fluoroscopy, echocardiography, computed tomography, or other modalities may be useful when migration, thrombus, perforation, or retrieval difficulty is suspected.
Clinicians and trainees can also benefit from comparing registry outcomes with individual device interrogations. A broad evidence base helps distinguish expected aging from an unusual complication. When reviewing online material, readers should prioritize peer-reviewed data and recognize that unrelated digital content may have a different purpose; for example, this Ethereum gambling story illustrates why subject and source context matter when navigating web-based information.
Practical Priorities For Clinical Teams
A durable program combines technical monitoring with forward planning. The following priorities can help organize care across implantation, routine surveillance, and eventual replacement:
- Document baseline sensing, capture threshold, impedance, implant position, and pacing dependence.
- Use remote monitoring to identify electrical changes early, while retaining scheduled clinical assessments.
- Reassess the patient’s rhythm diagnosis and pacing requirement before battery depletion.
- Refer complex chronic retrieval or suspected device infection to a center with extraction expertise.
- Discuss replacement, retrieval, and alternative pacing strategies before the elective replacement window.
Leadless pacemakers offer meaningful advantages, but their long-term success depends on matching the device to the patient’s rhythm, anatomy, and likely future needs. The strongest outcomes will come from careful selection, consistent interrogation, transparent counseling, and multidisciplinary preparation for the first replacement decision.
Clinicians and researchers contributing new evidence can review the journal’s author submission guidance and help expand the evidence base on chronic retrieval, battery management, infection, and next-generation leadless pacing.